Sutro Biopharma (STRO) Enterprise Value (2016 - 2025)
Sutro Biopharma recorded quarterly Enterprise Value of -$141.4 million in Q4 2025, up 15.61% quarter-over-quarter from -$167.6 million in Q3 2025, and up 55.37% year-over-year from -$91.0 million in Q4 2024.
Sutro Biopharma's Enterprise Value history runs 10 years deep, the most recent figure standing at -$141.4 million for Q4 2025.
- In Q4 2025, Enterprise Value rose 55.37% year-over-year to -$141.4 million; the TTM figure through Dec 2025 stood at -$141.4 million (up 55.37% YoY), while the FY2025 annual figure was -$141.4 million, up 55.37% from the prior year.
- Enterprise Value came in at -$141.4 million for Q4 2025 at Sutro Biopharma, up from -$167.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$91.7 million in Q2 2021 to a low of -$388.3 million in Q3 2024.
- A 5-year average of -$210.6 million and a median of -$197.5 million in 2021 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 63.22% in 2023 and sank 184.96% in 2024, its largest moves.
- Sutro Biopharma's Enterprise Value stood at -$160.8 million in 2021, then sank by 88.08% to -$302.3 million in 2022, then jumped by 63.22% to -$111.2 million in 2023, then tumbled by 184.96% to -$316.9 million in 2024, then jumped by 55.37% to -$141.4 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$141.4 million, -$167.6 million, and -$205.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - | -141.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -141.43 Mn |
| Sep 30, 2025 | -167.59 Mn |
| Jun 30, 2025 | -205.13 Mn |
| Mar 31, 2025 | -248.97 Mn |
| Dec 31, 2024 | -316.90 Mn |
| Sep 30, 2024 | -388.25 Mn |
| Jun 30, 2024 | -141.21 Mn |
| Mar 31, 2024 | -267.60 Mn |
| Dec 31, 2023 | -111.21 Mn |
| Sep 30, 2023 | -321.11 Mn |
| Jun 30, 2023 | -268.44 Mn |
| Mar 31, 2023 | -251.47 Mn |
| Dec 31, 2022 | -302.34 Mn |
| Sep 30, 2022 | -133.69 Mn |
| Jun 30, 2022 | -113.12 Mn |
| Mar 31, 2022 | -171.40 Mn |
| Dec 31, 2021 | -160.76 Mn |
| Sep 30, 2021 | -189.94 Mn |
| Jun 30, 2021 | -91.67 Mn |
| Mar 31, 2021 | -220.27 Mn |
| Dec 31, 2020 | -326.49 Mn |
| Sep 30, 2020 | -143.24 Mn |
| Jun 30, 2020 | -201.36 Mn |
| Mar 31, 2020 | -115.39 Mn |
| Dec 31, 2019 | -117.86 Mn |
| Sep 30, 2019 | -125.16 Mn |
| Jun 30, 2019 | -153.16 Mn |
| Mar 31, 2019 | -170.57 Mn |
| Dec 31, 2018 | -204.49 Mn |
| Sep 30, 2018 | -122.95 Mn |
| Jun 30, 2018 | -25.44 Mn |
| Mar 31, 2018 | -6.65 Mn |
| Dec 31, 2017 | -22.02 Mn |
| Sep 30, 2017 | -25.42 Mn |
| Dec 31, 2016 | -11.87 Mn |